Not scared here. Just don't have any new information and won't bother with posts like "this thing is going to the moon!". We'll all wait and see.
Things I took out of the past few weeks:
1) AXIM presentation slides lists us as the key player in manufacturing of CBD, which is an area that is expected to have the largest growth in the next few years.
2) Chinese CBD oil selects Plus CBD oil over all competitors to sell overseas in China.
3) Joseph Dowling mentions in his presentation at NobleCon that CVSciences is currently in talks with the FDA to gain information on clinical trials - expecting to have more information by end of Q1. This is something that wasn't mentioned in previous similar presentations, so it looks like progress is being made.
4) CV Sciences continues to present at microcap and pharmaceutical conferences to get the word out on their patent-pending CVSI-007 candidate. I don't think a company would continually attend these conferences promoting a product that doesn't have a good chance of happening - it would look extremely bad and could kill the company if it doesn't get approved for a patent or clinical trials.
5) Noticing more employees popping up on LinkedIn for CV Sciences. Joseph Dowling recently changed his information to reflect his title at CV Sciences, he used to not have it listed. He has his name tied to its success now.
6) Earnings report should be out in a month. I don't see how expanding to hundreds of more stores could be a negative impact, so I'm curious to see how positive it will be.
I think the signs are there in front of our faces... that's why I'm in for 106.5k shares (0.38 cost basis) and plan to hold until the pharmaceutical goals are realized. Could be a year, could be two or three, I'm not in a hurry. I'm already tapped out and have a house I'm saving up for so won't be buying anymore for at least 6 months to a year, which is why I'm sharing this information with whoever else wants to get in to hopefully see some short term price spikes.
